Transformative applications of oculomics-based AI approaches in the management of systemic diseases: A systematic

Zhongwen Li1, Shiqi Yin2, Shihong Wang2

  • 1Ningbo Key Laboratory of Medical Research on Blinding Eye Diseases, Ningbo Eye Institute, Ningbo Eye Hospital, Wenzhou Medical University, Ningbo 315040, China; National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.

PubMed

Insights

Artificial intelligence (AI) using eye imaging (oculomics) shows promise for managing systemic diseases. This cost-effective, non-invasive approach aids early detection and staging, improving patient outcomes.

Area of Science:

  • Ophthalmology
  • Artificial Intelligence
  • Medical Diagnostics

Background:

  • Systemic diseases present significant global health challenges with high mortality rates.
  • Current diagnostic methods are often complex, expensive, and invasive, hindering timely detection.
  • There is a need for cost-effective, non-invasive methods for systemic disease management.

Purpose of the Study:

  • To systematically review the use of artificial intelligence (AI) algorithms in managing systemic diseases.
  • To analyze the potential of oculomics (ophthalmic features) for disease management.
  • To assess AI's accuracy and feasibility using non-invasive ophthalmic imaging.

Main Methods:

  • Systematic review of studies applying AI to ophthalmic data for systemic disease management.
  • Analysis of oculomics-based AI algorithms for prediction and staging.
  • Evaluation of study quality and potential biases.

Main Results:

  • AI demonstrates promising accuracy in predicting systemic diseases using oculomics.
  • AI shows potential for disease staging, though caution is needed regarding low-quality studies.
  • Oculomics-based AI systems are cost-effective, safe, and well-accepted by patients and clinicians.

Conclusions:

  • Oculomics-based AI holds significant potential for revolutionizing systemic disease management.
  • AI offers a viable, non-invasive strategy for early detection, diagnosis, and monitoring.
  • Further high-quality research is essential to fully realize the capabilities of AI in oculomics.
Abstract

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
508
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
438
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
393